Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

ATB Capital Markets analyst Martin Toner has to maintained his “Outperform” rating and $210.00 price target on KXS.